Healthcare -
Biotechnology - NASDAQ - US
$ 5.5
5.16 %
$ 49 M
Market Cap
-11.22
P/E
ICCC - CAPITAL EXPENDITURES
Capital Expenditures ICCC - ImmuCell Corporation
-1.89 M
LAST VALUE
14.83%
2 YEAR CAGR
1.39%
5 YEAR CAGR
-12.22%
10 YEAR CAGR